Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APT Comparison Study
NCT06972056Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jul 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atogepant in migraine, sponsored by Mayo Clinic. Started Jul 2025; status: recruiting.
02
Drugs
atogepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06972056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972056.